HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrea C LeBlanc Selected Research

Cysteine (L-Cysteine)

9/2015Methylene Blue Inhibits Caspases by Oxidation of the Catalytic Cysteine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrea C LeBlanc Research Topics

Disease

10Alzheimer Disease (Alzheimer's Disease)
01/2021 - 08/2004
7Cognitive Dysfunction
01/2021 - 07/2013
2Carcinoma (Carcinomatosis)
01/2017 - 09/2015
1Atrophy
01/2021
1Neuroinflammatory Diseases
12/2019
1Huntington Disease (Huntington's Disease)
01/2017
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2017
1Dementia (Dementias)
12/2016
1Neoplasms (Cancer)
09/2015
1Scrapie
07/2009
1Prion Diseases (Transmissible Spongiform Encephalopathies)
05/2007
1Amyloid Plaque
08/2004

Drug/Important Bio-Agent (IBA)

10Caspase 6IBA
01/2021 - 08/2004
3CaspasesIBA
12/2019 - 09/2015
2Methylene Blue (Methylthioninium Chloride)FDA Link
12/2019 - 09/2015
2Peptide Hydrolases (Proteases)FDA Link
01/2017 - 07/2013
2AntibodiesIBA
12/2016 - 08/2004
1Proteins (Proteins, Gene)FDA Link
01/2021
1Glial Fibrillary Acidic ProteinIBA
12/2019
1phenothiazineIBA
12/2019
1CalciumIBA
12/2019
1Cysteine Proteases (Cysteine Protease)IBA
01/2018
1divinyl sulfoneIBA
01/2017
1Aspartic Acid (Aspartate)FDA Link
01/2017
1Caspase InhibitorsIBA
01/2017
1Immune Sera (Antisera)IBA
12/2016
1Amyloid (Amyloid Fibrils)IBA
12/2016
1Azure AIBA
09/2015
1Cysteine (L-Cysteine)FDA Link
09/2015
1tau Proteins (tau Protein)IBA
09/2015
1Azure BIBA
09/2015
1Amyloid beta-PeptidesIBA
07/2013
1Alkaline PhosphataseIBA
07/2009
1Endopeptidase K (Proteinase K)IBA
07/2009
1Prion ProteinsIBA
05/2007
1Caspase 3 (Caspase-3)IBA
08/2004